Acute Ischemic Stroke Intervention

Abstract Acute ischemic stroke (AIS) is the leading cause of disability worldwide and among the leading causes of mortality. Although intravenous tissue plasminogen activator (IV-rtPA) was approved nearly 2 decades ago for treatment of AIS, only a minority of patients receive it due to a narrow time...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2016-06, Vol.67 (22), p.2631-2644
Hauptverfasser:	Khandelwal, Priyank, MD, Yavagal, Dileep R., MD, MBBS, Sacco, Ralph L., MD, MS
Format:	Artikel
Sprache:	eng
Schlagworte:	Brain - diagnostic imaging Cardiology Cardiovascular Endovascular Procedures FDA approval Fibrinolytic Agents - therapeutic use Heart attacks Humans Internal Medicine large vessel occlusion Magnetic Resonance Angiography mechanical thrombectomy Medical imaging Mortality Neuroimaging NMR Nuclear magnetic resonance Patient Selection Randomized Controlled Trials as Topic stent retrievers Stroke Stroke - mortality Stroke - therapy stroke systems Thrombectomy - instrumentation Time-to-Treatment Tissue Plasminogen Activator - therapeutic use Tomography, X-Ray Computed Veins & arteries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!